X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3157) 3157
animals (2511) 2511
mice (1916) 1916
humans (1614) 1614
osteoclasts - drug effects (1363) 1363
rank ligand - metabolism (1224) 1224
osteoclasts - metabolism (1023) 1023
osteoclasts - cytology (980) 980
cell differentiation - drug effects (976) 976
cells, cultured (942) 942
male (929) 929
female (882) 882
rank ligand (843) 843
rankl (746) 746
osteoprotegerin (738) 738
rank ligand - pharmacology (697) 697
differentiation (686) 686
receptor activator of nuclear factor-kappa b (662) 662
osteoporosis (644) 644
osteoclast (604) 604
receptor activator (565) 565
cell line (556) 556
expression (540) 540
osteoclastogenesis (524) 524
rank ligand - genetics (509) 509
cell biology (496) 496
mice, inbred c57bl (494) 494
cells (485) 485
bone resorption (480) 480
biochemistry & molecular biology (477) 477
endocrinology & metabolism (475) 475
osteoblasts - drug effects (460) 460
osteoclasts (460) 460
osteogenesis - drug effects (452) 452
osteoblasts - metabolism (443) 443
bone-resorption (437) 437
rats (410) 410
osteoprotegerin - metabolism (405) 405
nf-kappa b - metabolism (403) 403
activation (402) 402
pharmacology & pharmacy (402) 402
bone (399) 399
signal transduction - drug effects (386) 386
nf-kappa-b (378) 378
in-vitro (358) 358
musculoskeletal diseases (357) 357
osteoclasts - physiology (348) 348
osteoclast differentiation (342) 342
cell differentiation (341) 341
gene expression (336) 336
signal transduction (323) 323
rna, messenger - metabolism (322) 322
bone resorption - metabolism (314) 314
osteoclasts - pathology (310) 310
tartrate-resistant acid phosphatase (308) 308
gene expression regulation - drug effects (300) 300
analysis (298) 298
trance protein (296) 296
dentistry (291) 291
kappa-b ligand (290) 290
ligand (288) 288
immunology (285) 285
macrophage colony-stimulating factor - pharmacology (285) 285
rank ligand - antagonists & inhibitors (284) 284
bone marrow cells - cytology (281) 281
dose-response relationship, drug (280) 280
macrophages - drug effects (277) 277
osteoblasts (276) 276
reverse transcriptase polymerase chain reaction (262) 262
denosumab (261) 261
nfatc transcription factors - metabolism (259) 259
bone resorption - pathology (250) 250
membrane glycoproteins - metabolism (245) 245
membrane glycoproteins - pharmacology (244) 244
osteoblasts - cytology (240) 240
carrier proteins - pharmacology (238) 238
bone marrow cells - drug effects (237) 237
abridged index medicus (235) 235
inflammation (235) 235
carrier proteins - metabolism (234) 234
rheumatoid-arthritis (232) 232
coculture techniques (231) 231
gene-expression (227) 227
osteoprotegerin - genetics (227) 227
osteoprotegerin ligand (227) 227
article (225) 225
cytokines (222) 222
postmenopausal women (221) 221
medicine, research & experimental (220) 220
rna, messenger - genetics (219) 219
bones (218) 218
resorption (216) 216
bone density - drug effects (215) 215
dentistry, oral surgery & medicine (213) 213
receptor (212) 212
middle aged (208) 208
bone and bones - metabolism (206) 206
bone density conservation agents - pharmacology (206) 206
macrophages (206) 206
macrophages - metabolism (206) 206
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3284) 3284
Chinese (59) 59
Japanese (31) 31
French (4) 4
Russian (4) 4
Hungarian (3) 3
Polish (3) 3
German (2) 2
Croatian (1) 1
Danish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2009, Volume 361, Issue 8, pp. 745 - 755
Men receiving androgen-deprivation therapy for nonmetastatic prostate cancer are at high risk for bone loss and fractures. This placebo-controlled study... 
ZOLEDRONIC ACID | MEDICINE, GENERAL & INTERNAL | PLACEBO | BONE-MINERAL DENSITY | FRACTURES | RISK | COMPLICATIONS | RANDOMIZED CONTROLLED-TRIAL | POSTMENOPAUSAL WOMEN | OSTEOPOROSIS | ALENDRONATE | Lumbar Vertebrae - injuries | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Fractures, Bone - epidemiology | Antibodies, Monoclonal - therapeutic use | Male | Osteoporosis - drug therapy | Prostatic Neoplasms - physiopathology | Bone Remodeling - drug effects | Incidence | Antibodies, Monoclonal, Humanized | Spinal Fractures - prevention & control | RANK Ligand - pharmacology | Injections, Subcutaneous | Aged, 80 and over | RANK Ligand - therapeutic use | Gonadotropin-Releasing Hormone - agonists | Lumbar Vertebrae - physiology | Prostatic Neoplasms - drug therapy | RANK Ligand - adverse effects | Osteoporosis - chemically induced | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Prostatic Neoplasms - surgery | Antibodies, Monoclonal - pharmacology | Spinal Fractures - epidemiology | Bone Density Conservation Agents - therapeutic use | Lumbar Vertebrae - drug effects | Denosumab | Bone Density Conservation Agents - pharmacology | Orchiectomy | Bone Density - drug effects | Androgen Antagonists - therapeutic use | Aged | Androgen Antagonists - adverse effects | Fractures, Bone - prevention & control | Osteoporosis | Bone density | Prostate cancer | Older people | Men | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 02/2009, Volume 24, Issue 2, pp. 182 - 195
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2009, Volume 361, Issue 8, pp. 756 - 765
Journal Article
Journal Article
Bone, ISSN 8756-3282, 2008, Volume 43, Issue 2, pp. 222 - 229
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 01/2010, Volume 25, Issue 1, pp. 72 - 81
Journal Article
NATURE, ISSN 0028-0836, 02/2011, Volume 470, Issue 7335, pp. 548 - 553
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2010, Volume 107, Issue 7, pp. 2989 - 2994
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 12/2010, Volume 207, Issue 13, pp. 2793 - 2798
Sphingosine-1-phosphate (S1P), a lipid mediator enriched in blood, controls the dynamic migration of osteoclast (OC) precursors (OPs) between the blood and... 
MEDICINE, RESEARCH & EXPERIMENTAL | MARROW | CELL-MIGRATION | CHEMOKINE | SPHINGOSINE-1-PHOSPHATE RECEPTORS | IMMUNOLOGY | EXPRESSION | T-CELLS | SPHINGOSINE 1-PHOSPHATE | Receptors, Lysosphingolipid - antagonists & inhibitors | RANK Ligand - metabolism | Recombinant Fusion Proteins - pharmacology | Receptors, Lysosphingolipid - deficiency | Green Fluorescent Proteins - genetics | Stem Cells - cytology | Osteoclasts - cytology | Stem Cells - metabolism | Recombinant Fusion Proteins - metabolism | Bone Remodeling - drug effects | Bone and Bones - drug effects | RANK Ligand - pharmacology | Flow Cytometry | Glutathione Transferase - genetics | RNA Interference | Bone and Bones - metabolism | Lysophospholipids - pharmacology | Receptors, Lysosphingolipid - genetics | Receptors, Chemokine - genetics | Bone and Bones - cytology | Pyrazoles - pharmacology | Cell Line | Green Fluorescent Proteins - metabolism | Mice, Inbred C57BL | Receptors, Chemokine - metabolism | Cells, Cultured | Glutathione Transferase - metabolism | Mice, Transgenic | Lysophospholipids - blood | Chemotaxis - drug effects | Osteoclasts - metabolism | Mice, Knockout | RANK Ligand - genetics | Sphingosine - pharmacology | Cell Movement - drug effects | Glutathione Transferase - pharmacology | Sphingosine - analogs & derivatives | Animals | Microscopy, Fluorescence - methods | Recombinant Fusion Proteins - genetics | Sphingosine - blood | Stem Cells - drug effects | Mice | Pyridines - pharmacology | CX3C Chemokine Receptor 1 | Osteoclasts - drug effects | Index Medicus | Brief Definitive Report
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 08/2010, Volume 25, Issue 8, pp. 1886 - 1894
Journal Article